Literature DB >> 15717153

Electroanatomical mapping and radiofrequency catheter ablation of atrial tachycardia originating from the recipient heart with recipient-to-donor atrio-atrial conduction after orthotopic heart transplantation.

Bharat K Kantharia1, Sabrina L Wilbur, Steven P Kutalek, Farooq A Padder.   

Abstract

Atrial tachycardias resulting from recipient-to-donor atrio-atrial conduction after orthotopic heart transplantation are difficult to treat. We present two patients in whom atrial tachycardia originating in the recipient heart were successfully treated by radiofrequency ablation guided by electroanatomical CARTO mapping system. These cases illustrate that such atrial tachycardia are curable by radiofrequency ablation. Electroanatomical CARTO mapping is useful in identifying the site of origin of the tachycardia and the atrio-atrial conduction sites.

Entities:  

Mesh:

Year:  2005        PMID: 15717153     DOI: 10.1007/s10840-005-5842-1

Source DB:  PubMed          Journal:  J Interv Card Electrophysiol        ISSN: 1383-875X            Impact factor:   1.900


  20 in total

1.  Interatrial conduction of atrial tachycardia in heart transplant recipients: potential pathophysiology.

Authors:  D Birnie; M S Green; J P Veinot; A S Tang; R A Davies
Journal:  J Heart Lung Transplant       Date:  2000-10       Impact factor: 10.247

2.  Less is more: 4:2:1 block.

Authors:  W H Maisel; W G Stevenson; S Tung; L E Blier; C B Brunckhorst
Journal:  Circulation       Date:  2001-09-04       Impact factor: 29.690

3.  Recipient to donor conduction of atrial tachycardia following orthotopic heart transplantation.

Authors:  W Lai; A Kao; M J Silka; B D Halperin; M Raitt; R Oliver; J H McAnulty; J Kron
Journal:  Pacing Clin Electrophysiol       Date:  1998-06       Impact factor: 1.976

4.  Atrial reentrant tachycardia after heart transplantation.

Authors:  E Hoffmann; C Reithmann; P Nimmermann; T Remp; G Steinbeck
Journal:  Circulation       Date:  1999-01-19       Impact factor: 29.690

5.  Evaluation of early postoperative results after bicaval versus standard cardiac transplantation and review of the literature.

Authors:  C A Milano; A S Shah; P Van Trigt; J Jaggers; R D Davis; D D Glower; M B Higginbotham; S D Russell; K P Landolfo
Journal:  Am Heart J       Date:  2000-11       Impact factor: 4.749

6.  Influence of bicaval anastomoses on late occurrence of atrial arrhythmia after heart transplantation.

Authors:  M Brandt; W Harringer; S W Hirt; K P Walluscheck; J Cremer; H H Sievers; A Haverich
Journal:  Ann Thorac Surg       Date:  1997-07       Impact factor: 4.330

7.  Linear ablation lesions for control of unmappable ventricular tachycardia in patients with ischemic and nonischemic cardiomyopathy.

Authors:  F E Marchlinski; D J Callans; C D Gottlieb; E Zado
Journal:  Circulation       Date:  2000-03-21       Impact factor: 29.690

8.  Atrial tachycardia with recipient-to-donor atrioatrial conduction and isthmus-dependent donor atrial flutter in a patient after orthotopic heart transplantation. Successful treatment by radiofrequency catheter ablation.

Authors:  Dominique Fournet; Marc Zimmermann; Claude Campanini
Journal:  J Heart Lung Transplant       Date:  2002-08       Impact factor: 10.247

9.  Recipient-to-donor atrioatrial conduction after orthotopic heart transplantation: surface electrocardiographic features and estimated prevalence.

Authors:  D C Lefroy; J C Fang; L W Stevenson; L H Hartley; P L Friedman; W G Stevenson
Journal:  Am J Cardiol       Date:  1998-08-15       Impact factor: 2.778

Review 10.  Catheter ablation of supraventricular tachycardia in the transplanted heart: a case series and literature review.

Authors:  Anthony R Magnano; Hasan Garan
Journal:  Pacing Clin Electrophysiol       Date:  2003-09       Impact factor: 1.976

View more
  1 in total

Review 1.  Targeting atrio-atrial conduction in the post-orthotopic heart transplant patient.

Authors:  Pipin Kojodjojo; Prapa Kangaratnam; Vias Markides; Nicholas S Peters
Journal:  J Interv Card Electrophysiol       Date:  2005-06       Impact factor: 1.900

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.